MAPKAPK2 is also involved in chemotherapy (gemcitabine) resistance and radiation resistance in pancreatic cancer (11, 18) and head and neck squamous cell carcinoma (6). This evidence concerns the gene MAPKAPK2 and familial pancreatic carcinoma.